Uvisan’s smallest full-power UV-C cabinet, disinfect and charge up to two headsets.
Cleanroom™ Whole-room, safe, programmable disinfection, in just 10 minutes.
Uvisan’s smallest full-power UV-C cabinet, disinfect and charge up to two headsets.
Cleanroom™ Whole-room, safe, programmable disinfection, in just 10 minutes.
When UV-C is described as being given “the green light”, it does not mean the technology is new or experimental. Instead, it reflects a critical shift in how UV-C disinfection is regulated, validated, and safely deployed.
Historically, UV-C light was proven to be highly effective at inactivating viruses, bacteria, and mould, but its use was largely restricted to unoccupied spaces due to safety concerns around direct exposure. Advances in engineering, containment, and dosage control have now changed that.
Today, certain UV-C systems have been independently tested, certified, and approved for safe use in real-world environments, including settings where people may be present. This “green light” comes from compliance with recognised UK and international safety standards, not marketing claims.
In practical terms, this means:
Crucially, approval is technology- and system-specific. Not all UV-C solutions are automatically safe for occupied spaces. Only products that meet the required safety, performance, and compliance criteria qualify, which is why certified, purpose-built systems are essential.
This regulatory clarity is what has enabled UV-C to move from a controlled, specialist tool to a trusted, frontline infection control solution.
Regulatory approval of UV-C disinfection technology is rooted in safety, exposure control, and proven effectiveness. While the germicidal properties of UV-C light have been understood for decades, only recently have specific systems met the stringent requirements needed for approval in occupied and operational environments.
Modern UV-C solutions are assessed against recognised UK, European, and international safety standards, which govern factors such as:
Approval is therefore not granted to UV-C light as a concept, but to individual technologies and system designs that demonstrate compliance through independent testing and certification.
This regulatory framework ensures that approved UV-C systems:
Importantly, this distinction helps organisations separate validated, compliant solutions from unregulated or inappropriate UV-C products that may pose safety concerns if deployed incorrectly.
As a result, UV-C has moved from a restricted, specialist application to a credible, regulator-backed infection control technology, suitable for use in demanding environments such as healthcare, transport, education, and high-footfall public spaces.
In the UK and internationally, the safe use of UV-C disinfection systems is governed by a framework of radiation safety, electrical safety, and product compliance standards. These standards exist to ensure that UV-C technology delivers effective pathogen control without posing a risk to human health.
Rather than a single approval body, UV-C systems are assessed against multiple recognised standards, depending on how and where they are used. These typically cover:
Internationally harmonised standards help ensure that UV-C systems approved for use in one region can meet comparable safety expectations elsewhere, supporting deployment across healthcare, transport, education, and public environments.
Crucially, compliance is system-specific, not technology-wide. A UV-C product must demonstrate that it:
For organisations, adherence to these standards provides reassurance that a UV-C solution can be integrated into infection control strategies without introducing new safety risks, while also supporting governance, procurement, and risk management requirements.
This standards-based approach is what underpins the growing confidence in UV-C as a safe, regulated, and deployable disinfection technology at scale.
UV-C disinfection is now approved for use in certain occupied spaces because the way the technology is delivered has fundamentally changed. While traditional UV-C systems relied on high-intensity, direct exposure – making them unsuitable for use around people – modern systems are engineered to control, contain, and manage UV-C output safely.
Approval is driven by a combination of advanced system design and rigorous safety validation, including:
These engineering advances allow approved systems to deliver effective microbial inactivation while remaining safe for use in real-world environments where people are present.
Importantly, approval applies only to specific UV-C technologies and configurations that have demonstrated compliance through independent testing. This ensures that systems used in occupied spaces can support infection control objectives without increasing risk to staff, patients, or the public.
As a result, UV-C has evolved from a stop-start, room-emptying intervention into a continuous, background disinfection solution, one that complements existing cleaning protocols and enhances overall infection prevention strategies.
The future of infection control is moving towards automated, continuous, and compliance-led solutions that operate in the background of everyday environments. As expectations around hygiene, safety, and risk management continue to rise, disinfection can no longer rely solely on manual processes or reactive deep cleans.
Approved UV-C technologies are helping to shape this shift by providing consistent, repeatable pathogen reduction without disrupting daily operations. When engineered to meet recognised safety standards, UV-C systems can run continuously, supporting cleaner air and surfaces while reducing reliance on human intervention.
Crucially, automation does not replace existing infection prevention measures, it strengthens them. UV-C works alongside routine cleaning, ventilation, and operational protocols to create a layered, resilient approach to hygiene. This integrated model is increasingly favoured in healthcare, transport, education, and other high-footfall environments where risk must be managed proactively.
Looking ahead, the focus will continue to be on validated performance, transparent compliance, and intelligent system design. Technologies that can demonstrate long-term safety, reliability, and regulatory alignment will become the standard, not the exception.
In this context, UV-C is no longer an emerging concept. It is becoming a trusted, automated component of modern infection control strategies, helping organisations protect people, maintain confidence, and operate safely in an evolving risk landscape.
Whether you’re looking to protect your organisation from viruses and bacteria, extend device longevity, or deploy VR at scale safely, Uvisan delivers the confidence and compliance you need.
Explore Uvisan’s full UV-C range here.
Uvisan Limited
Kingswood House South Road
Bristol BS15 8JF